Projects

To strengthen healthcare systems worldwide and better prepare them for disease outbreaks, the GHPP globally supports projects that contribute to this goal.

Status
Regions
Countries
Institutes
7 Posts
Sort by

  • Title

    Subline here
    Info here
    Button Here

  • Title

    Subline here
    Info here
    Button Here

  • Title

    Subline here
    Info here
    Button Here

  • LabTrain

    Strengthening Capacity and Infrastructure Building in Drug Quality Assurance in African countries: A Contribution by BfArM to WHO Standards and good Laboratory Practice

    Status
    ongoing
    Duration
    2023 - 2025
    Partner Countries
    Ghana, Liberia, Sierra Leone, The Gambia
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 1,300,000 Euro
    More information

  • PharmTrain2

    Building Regulatory Capacities and Infrastructure: Marketing Authorisation of Medicinal Products

    Status
    ongoing
    Duration
    2023 - 2025
    Partner Countries
    Ghana, Liberia, Sierra Leone, South Africa, Südafrika, Tanzania, The Gambia, Zimbabwe
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 1,800,000 Euro
    More information

  • LEARN

    Cross-Project Enquiry into e-LEARNing Concepts Towards Supporting Sustainable Capacity Building in the Context of GHPP

    Status
    completed
    Duration
    2020 - 2022
    Partner Countries
    -
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 57,000 EUR
    More information

  • RegTrain – PharmTrain

    Regulatory Training and Advice in the Field of Pharmaceuticals

    Status
    completed
    Duration
    2019 - 2022
    Partner Countries
    Ghana, Liberia, Sierra Leone, The Gambia, Zimbabwe
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 1,600,000 EUR
    More information

  • DQA and DQA PLUS

    Training African National Drug Quality Control Laboratories (NDQCLs) in Quality Assurance and Quality Management in the Context of Combating Antimicrobial Resistance

    Status
    completed
    Duration
    2016 - 2022
    Partner Countries
    Botswana, Burkina Faso, Cameroon, Ethiopia, Ghana, Malawi, Namibia, Nigeria, Senegal, Sierra Leone, Zambia, Zimbabwe
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 3,200,000 EUR
    More information

  • PharmTrain – Corona Global

    Drug Regulation in Health Crises: Development of a Framework for the Regional Implementation of a Risk-based Procedure for the Evaluation of Unapproved Drugs (WHO-EUL) for Southern Africa

    Status
    completed
    Duration
    2021 - 2023
    Partner Countries
    Angola, Botswana, Comoros, Democratic Republic of the Congo, Eswatini, Lesotho, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South Africa, Südafrika, Tanzania, Zambia, Zimbabwe
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 230,000 EUR
    More information

  • CPA und CPA PLUS

    Combating Resistance in the Treatment of Infectious Diseases by Promoting Judicious/Rational Use of Anti-infective Drugs

    Status
    completed
    Duration
    2016 - 2022
    Partner Countries
    Malawi, Zambia, Zimbabwe
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 1,100,000 EUR
    More information